Live sessions agenda - 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling

2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling

2024 - Sleep apnea and its consequences: from animal models to precision medicine

2023 - In Vitro Diagnostic (IVD) tests to combat antimicrobial resistance in community-acquired low-respiratory tract infections (CA-LRTI)

2019 - New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

Introduction and Welcome

P. Hassoun (Baltimor, United States of America)

Slides

Accompanying documents

BMP receptor-dependent control of matrix production in PAH

P. Jones (Philadelphia, United States of America)

Accompanying documents

Right Ventricular Failure in an Animal Model of Severe Pulmonary Arterial Hypertension: eNOS Uncoupling and Protein Kinase G Signaling in the Transition from Adaptive to Maladaptive Remodeling

M. Crow (Baltimore, United States of America)

Slides

Accompanying documents

Lessons from transgenic models of pulmonary hypertension

D. Rodman (Horsham, United Kingdom)

Slides

Accompanying documents

The genetics of pulmonary arterial hypertension

R. Trembath (Leicester, United Kingdom)

Slides

Serotonin and pulmonary vascular remodelling

S. Adnot (Creteil, France)

Slides

Accompanying documents

Relationship of BMPR2 mutations and vasoreactivity in pulmonary arterial hypertension

C. Elliott (Salt Lake City, United States of America)

Slides

Accompanying documents

Endothelial control of BMPR2 signalling in experimental shunt-induced pulmonary arterial hypertension

R. Naeije (Brussels, Belgium)

Slides

Accompanying documents

The dual role of apoptosis in pulmonary hypertension

R. Tuder (Baltimore, United States of America)

Slides

Accompanying documents

The pro-proliferative phenotype of pulmonary microvascular endothelium

T. Stevens (Mobile, United States of America)

Slides

Accompanying documents

Role of progenitor cells in lung vascular repair: A novel approach for the treatment of pulmonary hypertension

D. Stewart (Queen Wing Toronto, Canada)

Slides

Accompanying documents

Imaging of angiogenesis

D. McDonald (San Francisco, United States of America)

Accompanying documents

Systemic neovascularization of the lung after left pulmonary artery obstruction

E. Wagner (Baltimor, United States of America)

Accompanying documents

Inflammation and the plexiform lesion

N. Voelkel (Denver, United States of America)

Slides

Accompanying documents

Cytokines and chemokines in pulmonary vascular remodelling

M. Humbert (Clamart, France)

Slides

Accompanying documents

Smooth muscle cell heterogeneity and transdifferentiation

K. Stenmark (Denver, United States of America)

Slides

Accompanying documents

A Disordered Mitochondria-HIF-Kv Pathway Contributes to PAH in Fawn Hooded Rats and Humans

S. Archer (Edmonton, Canada)

Accompanying documents

CDN Connection Issue

2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling

2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling

#{title}